Researchers at the University of Georgia are developing a new treatment technique that uses nanoparticles to reprogram immune cells so they are able to recognize and attack cancer.
The findings were published recently in the early online edition of ACS Nano.
The human body operates under a constant state of martial law. Chief among the enforcers charged with maintaining order is the immune system, a complex network that seeks out and destroys the hordes of invading bacteria and viruses that threaten the organic society as it goes about its work.
The immune system is good at its job, but it’s not perfect. Most cancerous cells, for example, are able to avoid detection by the immune system because they so closely resemble normal cells, leaving the cancerous cells free to multiply and grow into life-threatening tumors while the body’s only protectors remain unaware.
Shanta Dhar and her colleagues are giving the immune system a boost through their research.
“What we are working on is specifically geared toward breast cancer,” said Dhar, the study’s co-author and an assistant professor of chemistry in the UGA Franklin College of Arts and Sciences. “Our paper reports for the first time that we can stimulate the immune system against breast cancer cells using mitochondria-targeted nanoparticles and light using a novel pathway.”
In their experiments, Dhar and her colleagues exposed cancer cells in a petri dish to specially designed nanoparticles 1,000 times finer than the width of a human hair. The nanoparticles invade the cell and penetrate the mitochondria—the organelles responsible for producing the energy a cell needs to grow and replicate.
They then activated the nanoparticles inside the cancer cells by exposing them to a tissue-penetrating long wavelength laser light. Once activated, the nanoparticles disrupt the cancer cell’s normal processes, eventually leading to its death.
The dead cancer cells were collected and exposed to dendritic cells, one of the core components of the human immune system. What the researchers saw was remarkable.
“We are able to potentially overcome some of the traditional drawbacks to today’s dendritic cell immunotherapy,” said Sean Marrache, a graduate student in Dhar’s lab. “By targeting nanoparticles to the mitochondria of cancer cells and exposing dendritic cells to these activated cancer cells, we found that the dendritic cells produced a high concentration of chemical signals that they normally don’t produce, and these signals have traditionally been integral to producing effective immune stimulation.”
Dhar added that the “dendritic cells recognized the cancer as something foreign and began to produce high levels of interferon-gamma, which alerts the rest of the immune system to a foreign presence and signals it to attack. We basically used the cancer against itself.”
The Latest Bing News on:
Nanoparticles to fight cancer
- Genprex targets non-small cell lung cancer and diabetes via gene therapyon April 6, 2021 at 8:36 pm
REQORSA uses the company’s unique, proprietary ONCOPREX nanoparticle delivery system which provides cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanoparticles.
- Gene Therapies Receive a Shot in the Armon April 2, 2021 at 4:05 am
TUSC2 is delivered via the company’s Oncoprex technology, which relies on positively charged lipid nanoparticles that have an affinity for negatively charged cancer cells. Reqorsa interrupts ...
- Cello Therapeutics’ Platelet Membrane-Coated Nanoparticles Offer a Novel Platform for the Delivery of Immunotherapy in Cancer Treatmenton March 31, 2021 at 8:01 pm
About Cello Therapeutics Inc.: Founded in 2016 in San Diego, CA, Cello is an emerging biotechnology company focused on developing novel nanoparticle delivery platforms for cancer treatment. Taking ...
- Cello Therapeutics’ Platelet Membrane-Coated Nanoparticles Offer a Novel Platform for the Delivery of Immunotherapy in Cancer Treatmenton March 31, 2021 at 7:59 pm
About Cello Therapeutics Inc.: Founded in 2016 in San Diego, CA, Cello is an emerging biotechnology company focused on developing novel nanoparticle delivery platforms for cancer treatment.
- 'Waltzing' Nanoparticles Target Medication Deliveryon March 30, 2021 at 5:00 pm
Pictured is a "dance pair" of nanoparticles dyed red and green to reveal molecular ... which uses the body’s own immune system to fight diseases like cancer and depends partially on the ability to ...
- Matinas BioPharma Holdings, Inc.'s (MTNB) CEO Jerome Jabbour on Q4 2020 Results - Earnings Call Transcripton March 29, 2021 at 10:15 am
Unlike lipid nanoparticles and viral vectors ... 3 with the capability of achieving elevated blood levels of EPA in the fight against cardiovascular risk. With a cash runway into 2024, and ...
- Modified blood platelets combine heat and immunotherapy to kill canceron March 29, 2021 at 7:42 am
Researchers at the Chinese Academy of Sciences (CAS) have developed an intriguing new way to fight cancer by combining two types of experimental therapies. Their secret ingredient is creating a ...
- Keeping covid vaccines cold isn’t easy. These ideas could help.on March 29, 2021 at 2:34 am
But messenger RNA (mRNA) vaccines such as those by Pfizer and Moderna, which have proved more effective and will be far easier to modify to fight new ... bubble is a lipid nanoparticle—which ...
The Latest Google Headlines on:
Nanoparticles to fight cancer
The Latest Bing News on:
Nanoparticles to reprogram immune cells
- Nammi Therapeutics Unveils Two Novel Immunotherapies at AACR Conferenceon April 9, 2021 at 8:01 am
Nammi's Nammisome platform combines immune modulating prodrugs into lipid nanoparticles enabling selective delivery to tumors. A second immunotherapy platform called Masked ImmunoCytokines (MICs ...
- An Alphavirus-derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primateson April 5, 2021 at 5:00 pm
Prime/boost vaccination of mice and macaques also induced T cell responses that could potentially contribute to protection. This RNA vaccine also induced robust immune responses ... formulated with ...
- Tattoo made of gold nanoparticles revolutionizes medical diagnosticson April 5, 2021 at 5:00 pm
There is also the problem of implant rejection as the immune system ... has been using gold nanoparticles as sensors to detect tiny amounts of proteins in microscopic flow cells for many years.
- Ionizable lipid nanoparticles for in utero mRNA deliveryon April 4, 2021 at 5:01 pm
immature immune system, and abundance of progenitor cells. However, the development of nonviral platforms for prenatal delivery is nascent. We developed a library of ionizable lipid nanoparticles ...
- Frank A. Bures: Range of immune reactions to COVID vaccineson April 4, 2021 at 9:22 am
There is a range of immune system reactions ... and coated with fatty or lipid nanoparticles to protect it from destruction and allow absorption by our muscle cells which begin manufacturing ...
- The powerful technology behind the Pfizer and Moderna vaccineson April 2, 2021 at 5:50 pm
Our DNA resides inside the nucleus of our cells ... to stimulate the immune response in their recipients. In what Weissman described as a lucky development, lipid nanoparticles happened to ...
- Team identifies inflammation-fighting nanoparticles in honeyon April 1, 2021 at 8:00 am
along with the inflammation-related death of certain cells. And when the team injected mice with the vesicles, it found that the nanoparticles partly alleviated both inflammation and drug-induced ...
- Intratumoral immunotherapy using platelet-cloaked nanoparticles enhances antitumor immunity in solid tumorson March 31, 2021 at 4:46 am
The immunostimulatory properties of TLR7/8 agonists, such as resiquimod, have been exploited for cancer immunotherapy. Here, the authors design platelet membrane-cloaked nanoparticles for selective ...
- Nanoparticles elicit neutralizing antibodies to diverse SARS-CoV-2 variantson March 29, 2021 at 9:42 pm
Broad antibody responses need long-lived germinal center (GC) reactions to activate precursor B cells and form long-term immune memory ... a spike protein on three self-assembling protein ...
- Novavax coronavirus vaccine – all you need to knowon March 29, 2021 at 9:12 am
The Government has agreed a deal with pharmaceutical giant GlaxoSmithKline (GSK) on the manufacture of up to 60 million doses of the Novavax coronavirus vaccine. Here is what we k ...